An audit of acute oncology services: patient experiences of admission procedures and staff utilisation of a new telephone triage system

Warrington, Lorraine; Holch, Patricia; Kenyon, Lucille; Hector, Ceri; Kozlowska, Krystina; Kenny, Anne M.; Ziegler, Lucy; Velikova, Galina

doi:10.1007/s00520-016-3370-4

Cited by 26 publications

(20 citation statements)

References 4 publications

(5 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Many patients however, delay seeking care especially out of hours [3, 5]. This concurs with the findings of a UK enquiry into patient outcome and death (National Confidential Enquiry into Patient Outcome and Death, NCEPOD) which found that of patients dying within 30 days of systemic cancer therapy, 17% delayed seeking advice for over 24 h [6].…”

Section: Introductionsupporting

confidence: 62%

“…Severe AEs can escalate to hospitalisation for potentially life-threatening toxicities: 18% of cancer patients present to emergency services within 14 days of a scheduled hospital visit for symptom management (infection, fever, nausea/vomiting, pain, breathlessness) [1–4]. Patients with breast, gastrointestinal, colorectal cancers and those with metastatic disease are amongst those most likely to have emergency admissions [4, 5]. …”

Section: Introductionmentioning

confidence: 99%

“…This work was conducted via: staff interviews, a local audit of care pathways/acute triage processes, mapping the existing chemotherapy pathways for the detection and management of AE and an assessment of patient experience of acute admissions and prospective patient interviews and diaries during chemotherapy to record AEs and costs to patents and services. The latter aimed to develop a questionnaire for health economic analysis [5]. …”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Electronic patient self-Reporting of Adverse-events: Patient Information and aDvice (eRAPID): a randomised controlled trial in systemic cancer treatment

et al. 2017

Self Cite

View full text Add to dashboard Cite

BackgroundeRAPID (electronic patient self-Reporting of Adverse-events: Patient Information and aDvice) is an internet based system for patients to self-report symptoms and side effects (adverse events or AE) of cancer treatments. eRAPID allows AE reporting from home and patient reported data is accessible via Electronic Patient Records (EPR) for use in routine care. The system can generate alerts to clinical teams for severe AE and provides patient advice on managing mild AEs. The overall aims of eRAPID are to improve the safe delivery of cancer treatments, enhance patient care and standardise AE documentation.MethodsThe trial is a prospective randomised two-arm parallel group design study with repeated measures and mixed methods. Participants (adult patients with breast cancer on neo-adjuvant or adjuvant chemotherapy, colorectal and gynaecological cancer receiving chemotherapy) are randomised to receive the eRAPID intervention or usual care over 18 weeks of treatment. Participants in the intervention arm receive training in using the eRAPID system to provide routine weekly adverse event reports from home. Hospital staff can access eRAPID reports via the EPR and use the information during consultations or phone calls with patients.Prior to commencing the full trial an internal pilot phase was conducted (N = 87 participants) to assess recruitment procedures, consent and attrition rates, the integrity of the intervention information technology and establish procedures for collecting outcome data. The overall target sample for the trial is N = 504.The primary outcome of the trial is quality of life (FACT-G) with secondary outcomes including health economics (costs to patients and the NHS), process of care (e.g. contacts with the hospital, number of admissions, clinic appointments and changes to treatment/medications) and patient self-efficacy. Outcome data is collected at baseline, 6, 12, 18 weeks and 12 months. The intervention is also being evaluated via end of study interviews with patient participants and clinical staff.DiscussionThe pilot phase was completed in February 2016 and recruitment and attrition rates met criteria for continuing to the full trial. Recruitment recommenced in May 2016 and is planned to continue until December 2017. Overall findings will determine the value of the eRAPID intervention for supporting the care of patients receiving systemic cancer treatment.Trial registrationCurrent Controlled Trials ISRCTN88520246. Registered 11 September 2014.

show abstract

Section: Introductionsupporting

confidence: 62%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Electronic patient self-Reporting of Adverse-events: Patient Information and aDvice (eRAPID): a randomised controlled trial in systemic cancer treatment

et al. 2017

Self Cite

View full text Add to dashboard Cite

show abstract

“…Telephone communication is a unique opportunity to improve health care access, optimize patient coordination, and enhance the patient's experience outside the hospital setting. 12,23,24 During the day, our office RNs handle these calls and are continually coordinating patient care at all of the different sites we serve. After hours calls are handled by the physicians, APPs, and RNs who follow up with the office staff and communicate any issues that may have arisen overnight and need to be addressed.…”

Section: Outpatient Clinicmentioning

confidence: 99%

Advanced Practice Professionals and an Outpatient Clinic: Improving Longitudinal Care in an Interventional Radiology Practice

Crum¹,

Varma²

2019

Semin intervent Radiol

View full text Add to dashboard Cite

The field of interventional radiology (IR) has made tremendous advances in both scope and practice since its inception in the early 1960s. With these advances, it has solidified itself as a valuable subspecialty to the medical community and, most importantly, to the patients who receive IR care. Expanding clinical services to improve care in both the pre- and postprocedural setting is a logical step in IR maturation. The use of advanced practice professionals, in the form of physician assistants and nurse practitioners, can add value in both quality of the patient experience and exposure to other subspecialties. Furthermore, a dedicated outpatient clinic provides a centralized site to evaluate patients and communicate with referring services. These additions can be a challenging value proposition, particularly when working in a combined diagnostic radiology and IR practice, but given the benefits, these are well worth the time and monetary investments.

show abstract

“…In this two-centre study, professional and patient care pathways and the role of eRAPID were explored via audit and interviews with staff, patients and relatives [ 49 – 51 ]. Additionally, we identified the AEs associated with urological, gastrointestinal and gynaecological cancers from patient interviews [ 50 ] and via systematic reviews of PRO reporting for these groups [ 52 – 54 ].…”

Section: Introductionmentioning

confidence: 99%

eRAPID electronic patient self-Reporting of Adverse-events: Patient Information and aDvice: a pilot study protocol in pelvic radiotherapy

Holch

Pini

Henry

et al. 2018

Pilot Feasibility Stud

Self Cite

View full text Add to dashboard Cite

BackgroundAn estimated 17,000 patients are treated annually in the UK with radical radiotherapy (RT) for pelvic cancer. New treatment approaches in RT have increased survivorship and changed the subjective toxicity profile for patients who experience acute and long-term pelvic-related adverse events (AE). Multi-disciplinary follow-up creates difficulty for monitoring and responding to these events during treatment and beyond. Originally developed for use in systemic oncology therapy eRAPID (electronic patient self-Reporting of Adverse-events: Patient Information and aDvice) is an online system for patients to report AEs from home. eRAPID enables patient data to be integrated into the electronic patient records for use in clinical practice, provides patient management advice for mild and moderate AE and advice to contact the hospital for severe AE. The system has now been developed for pelvic RT patients, and we aim to test the intervention in a pilot study with staff and patients to inform a future randomised controlled trial (RCT).MethodsEligible patients are those attending St James’s University hospital cancer centre and The Christie Hospital Manchester undergoing pelvic radiotherapy+/−chemotherapy/hormonotherapy for prostate, lower gastrointestinal and gynaecological cancers. A prospective 1:1 randomised (intervention or usual care) parallel group design with repeated measures and mixed methods will be employed. We aim to recruit 168 patients following recommendations for sample size estimates for pilot studies. Participants using eRAPID will report AE (at least weekly) from home weekly for 6 weeks and 6 weeks post-treatment (12-week total) then at 18 and 24 weeks. Hospital staff will review eRAPID reports and use information during consultations. Notifications will be sent to the relevant clinical team when severe symptoms are reported. We will measure patient-reported outcomes using validated questionnaires (Functional Assessment in Cancer Therapy Scale-General (FACT-G), European Organisation for Research and Treatment of Cancer Core Quality of Life questionnaire (EORTC-QLQ-C30), process of care impact (hospital records of patient contacts and admissions) and economic variables (EQ5D-5L, patient use of resources)). Staff and patient experiences will be explored via semi-structured interviews.DiscussionThe objectives are to establish feasibility, recruitment, integrity of the system and attrition rates, determine effect sizes and aid selection of the primary outcome measure for a future RCT. We will also refine the intervention by exploring staff and patient views. The overall goal of this complex intervention is to improve the safe delivery of cancer treatments, enhance patient care and standardise documentation of AE within the clinical datasets.Trial registrationClinicalTrials.gov NCT02747264.Electronic supplementary materialThe online version of this article (10.1186/s40814-018-0304-6) contains supplementary material, which is available to authorized users.

show abstract

An audit of acute oncology services: patient experiences of admission procedures and staff utilisation of a new telephone triage system

Cited by 26 publications

References 4 publications

Electronic patient self-Reporting of Adverse-events: Patient Information and aDvice (eRAPID): a randomised controlled trial in systemic cancer treatment

Electronic patient self-Reporting of Adverse-events: Patient Information and aDvice (eRAPID): a randomised controlled trial in systemic cancer treatment

Advanced Practice Professionals and an Outpatient Clinic: Improving Longitudinal Care in an Interventional Radiology Practice

eRAPID electronic patient self-Reporting of Adverse-events: Patient Information and aDvice: a pilot study protocol in pelvic radiotherapy

Contact Info

Product

Resources

About